The development of effective gene therapies for inherited disorders requires interdisciplinary programs that focus on the identification of disease genes, an elucidation of disease pathogenesis, and the development of technologies for genetic modulation. The Center's goal has been to provide investigators with the opportunity to improve and/or expand their gene therapy-based research. Although this Center has a primary focus on the development of gene therapies for cystic fibrosis (CF), as evidenced through two of its Research Cores that apply specialized airway model systems to CF research, it also maintains active research programs in molecular medicine for a diverse range of other genetic diseases. The Center has productively fostered gene therapy research through the following mechanisms. 1) The Center's Pilot and Feasibility Program, which has sponsored 50 pilots over the previous 9 years of funding, has brought numerous new Members and expertise into the Center while fostering the development of talented junior Associate Members into independent tenure-track faculty positions. 2) The Center has successfully established and expanded existing specialized Core facilities (Vector Core, Cell and Tissue Core, Cell Morphology and Pathology Core, and Animal Models Core) that are devoted to gene therapy research. These Cores have provided Center investigators with specialized vectors, human and mouse CF model systems, and methods that have allowed them to test hypotheses that could not otherwise be evaluated. The Center has also served as a resource for the distribution of viral vectors and CF models to numerous outside institutions. 3) By combining viral gene-targeting technologies with animal modeling, the Center has also created two new larger CF animal models, in the pig and ferret, to address the growing need for phenotypic models of human CF lung disease. 4) The Center has successfully maintained a CF Lung Tissue Acquisition Consortium of lung transplant centers, which has allowed for significant expansion of the humanized CF model systems. This consortium, which receives between 15-20 CF lung transplants per year, has also promoted numerous intrainstitutional collaborations on CF research that have led to new research programs. 5) The Center has also fostered interdisciplinary interactions and training through its Enrichment Programs, consisting of a centralized center website, a trainee seminar series, an external speaker seminar series, smaller informal research focus groups, and the annual Gene Therapy Center Retreat. 6) The Center has established formal internal and external mechanisms for review of the Center, the Cores, and the Pilot and Feasibility projects, thereby ensuring a high level of excellence and the most appropriate utilization of the Center's resources. In summary, the Center for Gene Therapy of Cystic Fibrosis and Other Genetic Diseases has greatly strengthened existing gene therapy-based research programs at the University of Iowa and consortium institutions, while also serving as a resource for other institutions that perform gene therapy and CF research. These efforts have led to numerous basic and applied research findings that have enhanced the utility of gene therapies to both study and treat genetic diseases.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-1 (J2))
Program Officer
Mckeon, Catherine T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Anatomy/Cell Biology
Schools of Medicine
Iowa City
United States
Zip Code
Weldon, Sinéad; McNally, Paul; McAuley, Danny F et al. (2014) miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med 190:165-74
Sui, Hongshu; Yi, Yaling; Yao, Jianrong et al. (2014) Quantifying insulin sensitivity and entero-insular responsiveness to hyper- and hypoglycemia in ferrets. PLoS One 9:e90519
Xie, Weiliang; Lynch, Thomas J; Liu, Xiaoming et al. (2014) Sox2 modulates Lef-1 expression during airway submucosal gland development. Am J Physiol Lung Cell Mol Physiol 306:L645-60
Hoegger, Mark J; Awadalla, Maged; Namati, Eman et al. (2014) Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs. Proc Natl Acad Sci U S A 111:2355-60
Sun, Xingshen; Olivier, Alicia K; Yi, Yaling et al. (2014) Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets. Am J Pathol 184:1309-22
Keiser, Megan S; Boudreau, Ryan L; Davidson, Beverly L (2014) Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy. Mol Ther 22:588-95
Gu, Xiaoling; Karp, Philip H; Brody, Steven L et al. (2014) Chemosensory functions for pulmonary neuroendocrine cells. Am J Respir Cell Mol Biol 50:637-46
Peng, Xinxia; Alföldi, Jessica; Gori, Kevin et al. (2014) The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease. Nat Biotechnol 32:1250-5
Swiderski, Ruth E; Nakano, Yoko; Mullins, Robert F et al. (2014) A mutation in the mouse ttc26 gene leads to impaired hedgehog signaling. PLoS Genet 10:e1004689
Schultz, Mark L; Tecedor, Luis; Stein, Colleen S et al. (2014) CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events. PLoS One 9:e96647

Showing the most recent 10 out of 301 publications